Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern
The Pharma Data
MARCH 16, 2022
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, It’s critical to quickly and accurately identify variants to inform ongoing research – including the ongoing development of therapeutics and vaccines. 3 and Delta.
52 
Let's personalize your content